In November 2023, Nestlé introduced a new product under its Wyeth illuma brand, a science-based growing-up milk enriched with Human Milk Oligosaccharides (HMOs) in mainland China. This development follows the recent approval by China's National Health Commission for the use of HMOs. The product aims to support early life nutrition by closely mimicking the benefits of human breast milk. This strategic move enhances Nestlé's position in the pediatric nutrition market, offering scientifically backed health benefits and meeting growing consumer demand for advanced infant formulas
